DSKX News Alert Ds Healthcare Group Inc (DSKX) 0.71 12/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ds Healthcare Group Inc (DSKX) 0.71 $DSKX

DS Healthcare wins regulatory approval to market its Spectral.LASH Eyelash extender in Brazil
M2 - Wed Nov 26, 4:06AM CST
Personal care products company DS Healthcare Group (NasdaqCM SKX) revealed on Tuesday the receipt of approval to market its Spectral.LASHeyelash extender product in Brazil.
DSKX: 0.71 (-0.05)

DS Healthcare Receives Regulatory Approval in Brazil to Market its Spectral.LASH Eyelash Extender
GlobeNewswire - Tue Nov 25, 8:45AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced that the Brazilian Health Surveillance Agency, ANVISA, has approved the Company's Spectral.LASHeyelash extender product for marketing in Brazil.
DSKX: 0.71 (-0.05)

DS Healthcare Group CEO Daniel Khesin featured on The Gray Zone
PR Newswire - Mon Nov 17, 1:48PM CST
DS Healthcare Group CEO Daniel Khesin was featured on The Gray Zone on 880 The Biz on Nov. 14 to announce the launch of the DS Laboratories Hair Recovery Clinic (www.dshairclinic.com) in Coral Gables.
DSKX: 0.71 (-0.05)

DS Healthcare revenues up 2.4% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:58AM CST

DSKX: 0.71 (-0.05)

DS Healthcare misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 7:51AM CST

DSKX: 0.71 (-0.05)

DS Healthcare Group Reports Third Quarter 2014 Financial Results As Company Reaches EBITDAS Profitability
GlobeNewswire - Mon Nov 17, 7:42AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and nine months ended September 30, 2014.
DSKX: 0.71 (-0.05)

DS Healthcare Group Issues Letter to Shareholders
GlobeNewswire - Fri Nov 14, 8:38AM CST
DS Healthcare Group, Inc. (NASDAQ SKX), a leading developer of personal care and specialty pharmaceutical products, today issued the following letter to shareholders:
DSKX: 0.71 (-0.05)

"New To The Street" Is Back on the Street
Marketwired - Thu Nov 13, 12:40PM CST
"New To The Street" was back on the street in NYC outside the See Thru Equity Conference, seethruequity.com, on 45th Street, interviewing several CEO's who were presenting at the micro-cap conference. We will be featuring these interviews on our website, NewToTheStreet.com on our segment called "On the Street Interviews."
DSKX: 0.71 (-0.05)

"New To The Street" to Broadcast Nationally
Marketwired - Tue Nov 11, 11:04AM CST
"New To The Street" will be airing nationally on the ION Network on December 4, 2014 at 9:30 am reaching 100M households.
DSKX: 0.71 (-0.05)

"New To The Street" Announces Upcoming Episodes, Clients, and Themes
Marketwired - Fri Nov 07, 2:30PM CST
"New To The Street" would like to introduce Hybrid Coating Technologies (OTCQB: HCTI) and its upcoming interview to be broadcast Monday, November 10th at 7:00 am on the ION Network WPXN, as well as our ongoing interviews with VizConnect (OTCQB: VIZC), HydroCarb Energy (OTCQB: HECC) and Larry Isen from the OTC Journal.
DSKX: 0.71 (-0.05)

"New To The Street" Television Show Completes an In-Depth Feature TV Interview With DS Healthcare Group (NASDAQ: DSKX)
Marketwired - Fri Oct 24, 1:48PM CDT
"New To The Street," a television show that profiles public companies across national TV networks and social media channels with in-depth anchor driven reporting, will be airing the first of a six-part series on Monday, October 27, 2014 at 7:00 am on ION's New York Flagship Station WPXN featuring DS Healthcare Group.
DSKX: 0.71 (-0.05)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 11:48AM CDT

SPRO: 1.63 (unch), SYNA: 64.73 (-0.50), ISR: 1.50 (-0.02), ADHD: 3.56 (+0.27), VTAE: 19.86 (-0.23), AEHR: 2.48 (-0.02), DSKX: 0.71 (-0.05), AMDA: 0.64 (-0.02), DRIV: 16.86 (+0.11), GIMO: 16.79 (+0.41), CBDE: 0.90 (+0.06), IVC: 16.08 (-0.26), P: 16.90 (-0.29), LAYN: 8.67 (+0.50), BJRI: 46.84 (-0.23), PGI: 10.37 (+0.16), HVB: 25.78 (+0.19), DRYS: 0.78 (-0.02), MMSI: 16.30 (+0.11)

UPDATE: "New to the Street" Locks in Mondays at 7:00am on ION's Flagstaff TV Station WPXN in New York Starting October 20th
Marketwire - Tue Sep 23, 11:56AM CDT
New to the Street will offer weekly access to our bio-type news series interviews with public and private company's CEO's every Monday at 7:00 am.
DSKX: 0.71 (-0.05)

DS Healthcare Group obtains regulatory sales approval in Middle East, reflecting 6% of the worldwide market
M2 - Fri Sep 05, 4:53AM CDT
Topical therapies company DS Healthcare Group reported on Thursday the receipt of regulatory approval for the sale of its products line in Middle East following its recent expansion into Brazil and China.
DSKX: 0.71 (-0.05)

DS Healthcare Group obtains regulatory approval in Middle East
GlobeNewswire - Thu Sep 04, 7:26AM CDT
This agreement comes on the heels of the Company's recent expansion into Brazil and China. International sales are a key driver of the Company's growth, as its breakthrough products are in high demand in Canada, Mexico, the UK, and Australia.
DSKX: 0.71 (-0.05)

DS Healthcare Group to Open its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies for Hair Loss
GlobeNewswire - Tue Sep 02, 7:07AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, today announced it will open its first DS Laboratories Hair Loss Clinic in Miami, Florida. Slated to open in the fourth quarter of 2014, the clinic will provide unique therapies and treatment options for patients who desire the most comprehensive approach to treating hair loss. A team of healthcare professionals led by a medical doctor will provide customized solutions with the most advanced proven technologies developed through DS Healthcare's clinical research to restore a full head of hair.
DSKX: 0.71 (-0.05)

DS Healthcare Group (DSKX) is Undervalued With Good Seasonality.
M2 - Fri Aug 22, 7:27AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has updated its research report today on DS Healthcare Group (NASDAQ: DSKX). The report highlights the short term bullish seasonality that has emerged, the SqueezeTrigger Price of $2.51 and the projected fundamental valuation of $5.50 per share.
DSKX: 0.71 (-0.05)

BUYINS.NET Issues DS Healthcare Group (DSKX) SqueezeTrigger Report
M2 - Fri Aug 15, 7:20AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on DS Healthcare Group (NASDAQ: DSKX) after releasing the latest short sale data through August 13, 2014. The total aggregate number of shares shorted since May 2010 is approximately 2.08 million shares. Approximately 30% of daily trading volume is short selling. The SqueezeTrigger price for all DSKX shares shorted is $2.51. A short squeeze is expected to begin when shares of DSKX close above the $2.51 SqueezeTrigger price.
DSKX: 0.71 (-0.05)

DS Healthcare Group Reports Second Quarter 2014 Financial Results
GlobeNewswire - Fri Aug 15, 7:15AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and six months ended June 30, 2014.
DSKX: 0.71 (-0.05)

DS Healthcare signs third distribution agreement in Brazil for personal care products
M2 - Thu Aug 07, 4:11AM CDT
Specialist pharmaceuticals company DS Healthcare Group (NasdaqCM SKX) announced on Wednesday that it signed a distribution agreement the Rio de Janerio-based wholesale pharmacy Drogaria Venancio.
DSKX: 0.71 (-0.05)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 69

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 131

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 169

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 53

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 161

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Leech Tishman Expands Healthcare Practice with Nelson Hardiman

Updated Category News Views 79

Leech Tishman Expands Its Healthcare Practice with Major Addition Leech Tishman is making a significant move in its growth strategy by merging with the respected healthcare firm, Nelson Hardiman. This collaboration is set to enhance Leech Tishman’s footprint in the healthcare sector, especially in the Southern California region, as they prepare to operate under the name...

Continue Reading
Schouw & Co. Announces Success in Share Buy-Back Program

Updated Category News Views 105

Schouw & Co. Share Buy-Back Program Overview Schouw & Co., a notable player in the business landscape, has embarked on an impactful share buy-back program that began recently. This strategic move allows the company to purchase shares worth up to DKK 50 million over a designated time frame, from January 2 to March 31. Such initiatives reflect the company's commitment to...

Continue Reading
Earnings Season Set to Shape Market Dynamics Amid Tariffs

Updated Category News Views 150

Understanding Market Sentiment During Earnings Season The upcoming earnings season presents an opportunity for Wall Street to shift its attention from external geopolitical factors to the internal dynamics of corporate performance. As companies prepare to unveil their second-quarter earnings reports, a closer look at how tariffs could influence consumer spending and,...

Continue Reading
Josh Ruben Joins the Board of PetVivo Holdings to Drive Growth

Updated Category News Views 316

Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) has announced the addition of Josh Ruben to its Board of Directors. This news comes from the company's efforts to further establish itself within the biomedical device sector aimed at improving the quality of life for companion animals. Transformational Leadership...

Continue Reading
Innovative Portable Solar and Wind Generator Concept Unveiled

Updated Category News Views 120

Your Sustainable Charging Solution We live in a time where sustainable energy solutions are becoming more paramount, and the invention of a portable solar and wind-powered generator meets that demand head-on. The concept builds on the idea that everyone deserves access to clean energy alternatives, especially for charging electronic devices. The Vision Behind the...

Continue Reading